System Transmission

Top Signal

100#1 JOB

Activity

2184Ripe

+961 today

System

Live1m

Terminal Asset View

stockNASDAQ

KZR

$6.85-4.60%

Kezar Life Sciences Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

47Neutral

Live Analysis Active

Company Mission

Kezar Life Sciences is a biotechnology company that researches and develops new medicines for serious diseases like autoimmune disorders and cancer. They work on creating drugs that target specific biological pathways involved in these diseases. The company makes money through research collaborations with other pharmaceutical companies and by advancing their drug candidates through clinical trials, with the goal of eventually selling approved medications.

KZR

Industry Context

Kezar operates in the biotechnology industry, which focuses on developing new medical treatments through scientific research. This sector is known for high volatility because company values depend heavily on clinical trial results and regulatory approvals.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

69Matrix

Market Momentum

52.9— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.3x— Normal Volume

Today's Change

-4.60%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing KZR across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:10 AM UTC

As-of 03-15-2026 06:54 UTC

Develops drugs to treat autoimmune diseases and cancer, making money by selling successful medicines to hospitals and pharmacies.

Weekly price range is narrowing near recent levels, suggesting the stock may be preparing for a significant move in either direction showing showing consolidation pattern.

Biotech sector remains volatile as investors watch for clinical trial results, which can dramatically impact small research companies.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...